Prometheus is committed to improving lives through the development and commercialization
of novel pharmaceutical and diagnostic products that enable physicians to provide
greater individualized patient care.
Noninvasive PROMETHEUS® FIBROSpect® NASH Test Measures Severity of Liver Fibrosis
New Test Monitors Therapeutic Ustekinumab Levels in IBD Patients
New Serum Test Is First to Measure and Monitor Mucosal Healing in Crohn's Disease
Introducing PROMETHEUS® IBcause™: Convenient All-in-One Diagnostic Test for Persistent Diarrhea